Drugs / Gelofusine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06977763 | Jul → Nov 2025 overdue | — | Nanjing Chia-tai Tianqing Pharmaceutical | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gelofusine | “the succinylated gelatin injection (trade name: Gelofusine) produced by B. Braun Melsungen AG is licensed” NCT06977763 ↗ |
| Known as | succinylated gelatin injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06977763 ↗ |